Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
ACRS Aclaris Therapeutics Potential Buyout
Aclaris Therapeutics, Inc.
Long
ACRS Aclaris Therapeutics Potential Buyout
By TopgOptions
Follow
Follow
Oct 23, 2023
7
3
3
Oct 23, 2023
ACRS Aclaris Therapeutics has 3 clinical trials releasing topline data this year and sufficient cash to fund their operations through the end of 2025.
ACRS is in Piper Sandler`s potential 12 biotech takeovers in 2023.
ACRS reached 52 week low today: $5.05.
Analysts Price Targets:
$21 The Goldman Sachs Group
$29 BTIG Research
$38 Cantor Fitzgerald
$43 HC Wainwright
Considering the above, I think ACRS might be an easy +3X!
Looking forward to read your opinion about it.
aclaris
aclaristherapeutics
ACRS
buyout
buysignal
Fundamental Analysis
Technical Indicators
rumors
stockstobuy
takeover
therapeutics
Trend Analysis
TopgOptions
Follow
Private Signals
patreon.com/PremiumOptionsSignals
BUYSELL indicators
tradingindicators.store/
TRADING COURSE
bit.ly/tradex
RESULTS
bit.ly/topgx
1%/DAY:
bit.ly/3F56VTW
BYBIT
partner.bybit.com/b/37880
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.